Proposals funded: Kim-Shapiro, Fleeson

January 17, 2012

• Congratulations to Daniel Kim-Shapiro, professor in physics, whose proposal entitled “The Effects of Selective Adenosine A2B Receptor Antagonist GC-6201 on Adensine-induced Red Blood Cells Sickling in SCD Patients” has been funded by the Gilead Sciences, Inc., and the University of Pittsburgh.
• Congratulations to Will Fleeson, the Ollen R. Nalley professor of psychology, whose proposal entitled “Integrating Process and Structure in Borderline Personality Disorder” has been funded by the National Institutes of Health.